Crocs director Ronald L. Frasch proposes $2.3M sale

Available on EDGAR 11/12/2026 - 06:34 PM EST Accepted by SEC EDGAR 11/12/2026 - 06:34 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Crocs, Inc. (CROX) director Ronald L. Frasch reported a proposed sale of 15,000 common shares, with an approximate sale date of October 30, 2026 and an aggregate market value of $2,301,855.00. The notice names UBS Financial Services Inc. as broker and Nasdaq as the securities exchange. It lists the shares as acquired through director compensation and says the amendment corrects acquisition information in the original notice.

Key Figures

Common shares proposed for sale: 15,000 shares Aggregate market value: $2,301,855.00 Common shares outstanding: 45,725,039 shares

3 metrics

Common shares proposed for sale 15,000 shares Approximate sale date October 30, 2026

Aggregate market value $2,301,855.00 For the proposed sale of common shares

Common shares outstanding 45,725,039 shares Number listed in the securities information

Key Terms

Aggregate Market Value

1 terms

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CROX shares does Ronald L. Frasch propose to sell?

Ronald L. Frasch, a Crocs director, reported a proposed sale of 15,000 common shares, with an approximate sale date of October 30, 2026 and an aggregate market value of $2,301,855.00. UBS Financial Services Inc. is named as broker.

How did Ronald L. Frasch acquire the CROX shares listed in the notice?

The amended notice lists the shares as acquired from Crocs, Inc. through director compensation, including 1,252 shares on June 9, 2026 and 1,521 shares on June 10, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK	0001160547
Filer CCC	XXXXXXXX
Previous Accession Number Of The Filing	0001969223-26-001105
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer	Crocs, Inc.
SEC File Number	000-51754
Address of Issuer	500 ELDORADO BOULEVARD BUILDING 5 BROOMFIELD COLORADO 80021
Phone	3038487000
Name of Person for Whose Account the Securities are To Be Sold	FRASCH RONALD
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd Weehawken NJ 07086	15000	2301855.00	45725039	10/30/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/16/2022	Director Compensation	Crocs, Inc.			2589	03/16/2022	Stock
Common	06/20/2023	Director Compensation	Crocs, Inc.			1415	06/20/2023	Stock
Common	06/04/2024	Director Compensation	Crocs, Inc.			1075	06/04/2024	Stock
Common	06/10/2025	Director Compensation	Crocs, Inc.			1521	06/10/2025	Stock
Common	06/09/2026	Director Compensation	Crocs, Inc.			1252	06/09/2026	Stock
Common	06/08/2015	Director Compensation	Crocs, Inc.			4909	06/08/2015	Stock
Common	06/14/2022	Director Compensation	Crocs, Inc.			2239	06/14/2022	Stock

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks	This amended filing, to the original 144 filed on October 30 2026, has the correct Acquisition information in the Securities to be Sold page.
Date of Notice	11/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Joseph Cassidy, for UBS Financial Services Inc, as attorney-in-fact for Ronald L Frasch
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)